Skip to Content

Medartis Holding AG Ordinary Shares MED

Morningstar Rating
CHF 76.20 −0.60 (0.78%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

MED is trading at a 383% premium.
Price
CHF 76.53
Fair Value
CHF 57.77
Uncertainty
High
1-Star Price
CHF 632.13
5-Star Price
CHF 35.35
Economic Moat
Mzqmrf
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MED is a good fit for your portfolio.

Trading Information

Previous Close Price
CHF 76.80
Day Range
CHF 75.3077.00
52-Week Range
CHF 63.5099.40
Bid/Ask
CHF 75.10 / CHF 77.00
Market Cap
CHF 1.03 Bil
Volume/Avg
1,948 / 4,571

Key Statistics

Price/Earnings (Normalized)
1,143.70
Price/Sales
4.49
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from EMEA and also has a presence in APAC, USA, LATAM, and North America.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
876

Comparables

Valuation

Metric
MED
CLTN
BOSN
Price/Earnings (Normalized)
1,143.7025.7322.81
Price/Book Value
3.783.244.73
Price/Sales
4.491.291.62
Price/Cash Flow
57.6417.3716.58
Price/Earnings
MED
CLTN
BOSN

Financial Strength

Metric
MED
CLTN
BOSN
Quick Ratio
1.560.781.04
Current Ratio
3.081.602.81
Interest Coverage
2.7620.2110.50
Quick Ratio
MED
CLTN
BOSN

Profitability

Metric
MED
CLTN
BOSN
Return on Assets (Normalized)
0.62%6.48%8.81%
Return on Equity (Normalized)
0.84%11.57%20.89%
Return on Invested Capital (Normalized)
0.92%8.32%11.76%
Return on Assets
MED
CLTN
BOSN
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesZghmvyvfWwdjkt$182.4 Bil
SYK
Stryker CorpMwgsnsqpsLnt$127.2 Bil
MDT
Medtronic PLCJwwrcqpTrfxzbh$113.7 Bil
BSX
Boston Scientific CorpKjpqknjqnLwlllpk$109.6 Bil
EW
Edwards Lifesciences CorpYtbyhtrpWgcrmv$54.3 Bil
DXCM
DexCom IncDjpftdsnzQfvw$52.2 Bil
PHG
Koninklijke Philips NV ADRBkxxchtLqbkfq$25.9 Bil
ZBH
Zimmer Biomet Holdings IncXjjrjtbyDwhc$24.9 Bil
ALGN
Align Technology IncKqlwjmyzHvyrjwq$20.6 Bil
SNN
Smith & Nephew PLC ADRBtdkvjklVrdxqv$11.4 Bil

Sponsor Center